MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

The mammalian cochlea is an extraordinary biomechanical system whose capacity for sensitivity and frequency discrimination hinges on intricate interactions between its passive structures and active ...

Disabling hearing loss affects one in every ten people and up to 25% of people over 60, according to the World Health Organization, and can have both genetic and environmental causes such as ...

Most cochlear nerves carry information from the cochlea to the brain, but about 5% send signals in the opposite direction: from the brain to the cochlea. The exact role of those fibers has been a ...

Medically reviewed by William Truswell, MD Key Takeaways The cochlear nerve is part of the eighth cranial nerve and is ...

Intra-arterial Paraplatin did not cause hearing loss in children with retinoblastoma, as shown by DPOAE testing. DPOAE testing is a noninvasive, reliable method for assessing cochlear function and ...

The FDA has granted accelerated approval to lunsotogene parvec-cwha (Otarmeni), an adeno-associated virus (AAV) vector–based ...

Like other sensory organs that allow mankind to experience the environment, the ear has long held a special fascination for scientists. In mammals, the inner workings of the ear are encased in the ...

Cognitive functioning improved 12 months after cochlear implantation for older adults with severe hearing loss and poor cognition, data from a single-center study showed. Among 21 cochlear implant ...